North America Compression Therapy Market
Market Report I 2025-09-01 I 350 Pages I Data Bridge Market Research
The North America compression therapy market is expected to reach USD 2,656,346.55 thousand by 2032 from USD 1,743,886.86 thousand in 2024, growing at a substantial CAGR of 5.4% in the forecast period of 2025 to 2032.
Market Segmentation:
North America Compression Therapy Market, By Product Technique (Static Compression Therapy and Dynamic Compression Therapy), Product Type (Compression Bandages, Garments For Lymphedema, Stockings For Venous Diseases, Compression Wraps, Pneumatic Compression Devices, and Compression Hosiery & Gauntlets), Application (Varicose Veins, Lymphedema, Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT), Venous Leg Ulcers, Wound Care, and Sports Injury Management), Patient Group (Adult, Geriatric, and Pediatric), Compression Level (Moderate Compression, Strong Compression, Mild Compression, and Very Strong Compression), Distribution Channels (Hospital, Retail Pharmacies, Ecommerce Platforms, Specialty Clinics, Medical Device Stores, Home Healthcare Providers, and Nursing Homes/Long-Term Care Facilities), Country (U.S., Canada, Mexico) -Industry Trends & Forecast To 2032
Overview of the North America Compression Therapy are:
Driver
- Increasing Sports Injuries & Accidents
Restrain
- Limited Reimbursement and Insurance Coverage
Opportunity
- Growth In Home Based Therapy
Market Players:
The key market players for North America compression therapy are listed below:
- Solventum (U.S.)
- Cardinal Health (U.S.)
- Smith+Nephew (U.K.)
- Essity Aktiebolag (publ) (Sweden)
- PAUL HARTMANN AG (Germany)
- Arjo (Sweden)
- Zimmer Biomet (U.S.)
- NIKE, Inc. (U.S.)
- McKesson Medical-Surgical Inc. (U.S.)
- Getinge (Sweden)
- Tactile Medical (U.S.)
- adidas AG (Germany)
- Enovis Corporation (U.S.)
- Molnlycke AB (Sweden)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- SIGVARIS GROUP - (Switzerland)
- Ofa Bamberg GmbH (Germany)
- Medline Industries, LP (U.S.)
- Juzo (Julius Zorn GmbH) (Germany)
- MEDI GmbH & Co. KG (Germany)
- AIROS Medical, Inc. (U.S.)
- Bauerfeind AG (Germany)
- BIOCOMPRESSION SYSTEMS (U.S.)
- ThermoTek (U.S.)
TABLE OF CONTENTS
1 INTRODUCTION 50
1.1 OBJECTIVES OF THE STUDY 50
1.2 MARKET DEFINITION 50
1.3 OVERVIEW OF THE NORTH AMERICA COMPRESSION THERAPY MARKET 50
1.4 LIMITATIONS 52
1.5 MARKETS COVERED 52
2 MARKET SEGMENTATION 56
2.1 MARKETS COVERED 56
2.2 GEOGRAPHICAL SCOPE 57
2.3 YEARS CONSIDERED FOR THE STUDY 58
2.4 CURRENCY AND PRICING 58
2.5 DBMR TRIPOD DATA VALIDATION MODEL 59
2.6 MULTIVARIATE MODELLING 62
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 63
2.8 DBMR MARKET POSITION GRID 64
2.9 MARKET APPLICATION COVERAGE GRID 65
2.10 VENDOR SHARE ANALYSIS 66
2.11 SECONDARY SOURCES 67
2.12 ASSUMPTIONS 67
3 EXECUTIVE SUMMARY 68
4 PREMIUM INSIGHTS 72
4.1 PESTAL ANALYSIS 74
4.2 PORTERS FIVE FORCES ANALYSIS 75
4.3 COST ANALYSIS BREAKDOWN 76
4.4 HEALTHCARE ECONOMY 77
4.4.1 HEALTHCARE EXPENDITURE 77
4.4.2 CAPITAL EXPENDITURE 77
4.4.3 CAPEX TRENDS 77
4.4.4 CAPEX ALLOCATION 77
4.4.5 FUNDING SOURCES 77
4.4.6 INDUSTRY BENCHMARKS 77
4.4.7 GDP RATIO IN OVERALL GDP 78
4.4.8 HEALTHCARE SYSTEM STRUCTURE 78
4.4.9 GOVERNMENT POLICIES 78
4.4.10 ECONOMIC DEVELOPMENT 78
4.5 INDUSTRY INSIGHTS 79
4.5.1 MICRO AND MACRO ECONOMIC FACTORS 79
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING 80
4.5.3 KEY PRICING STRATEGIES 81
4.6 INNOVATION TRACKER AND STRATEGIC ANALYSIS 82
4.6.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 82
4.6.1.1 JOINT VENTURES 82
4.6.1.2 MERGERS AND ACQUISITIONS 82
4.6.1.3 LICENSING AND PARTNERSHIP 82
4.6.1.4 TECHNOLOGY COLLABORATIONS 82
4.6.1.5 STRATEGIC DIVESTMENTS 82
4.6.2 NUMBER OF PRODUCTS IN DEVELOPMENT 82
4.6.3 STAGE OF DEVELOPMENT 83
4.6.4 TIMELINES AND MILESTONES 83
4.6.5 INNOVATION STRATEGIES AND METHODOLOGIES 83
4.6.6 RISK ASSESSMENT AND MITIGATION 83
4.6.7 FUTURE OUTLOOK 83
4.7 OPPORTUNITY MAP ANALYSIS 84
4.8 PATENT ANALYSIS - 85
4.8.1 PATENT QUALITY AND STRENGTH 85
4.8.2 PATENT FAMILIES 85
4.8.3 LICENSING AND COLLABORATIONS 86
4.8.4 COMPETITIVE LANDSCAPE 86
4.8.5 IP STRATEGY AND MANAGEMENT 87
4.8.6 OTHER OBSERVATIONS 87
4.9 REIMBURSEMENT FRAMEWORK 89
4.10 SUPPLY CHAIN ECOSYSTEM 90
4.10.1 PROMINENT COMPANIES 90
4.10.2 SMALL & MEDIUM SIZE COMPANIES 91
4.10.3 END USERS 91
4.11 TECHNOLOGY ROADMAP 92
4.12 TARIFFS & IMPACT ON THE MARKET 94
4.12.1 CURRENT TARIFF RATE(S) IN TOP-5 COUNTRY MARKETS 94
4.13 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 95
4.14 VENDOR SELECTION CRITERIA DYNAMICS 95
4.15 IMPACT ON SUPPLY CHAIN 96
4.15.1 RAW MATERIAL PROCUREMENT 96
4.15.2 MANUFACTURING AND PRODUCTION 96
4.15.3 LOGISTICS AND DISTRIBUTION 96
4.15.4 PRICE PITCHING AND POSITION OF MARKET 96
4.16 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 97
4.16.1 SUPPLY CHAIN OPTIMIZATION 97
4.16.2 JOINT VENTURE ESTABLISHMENTS 97
4.17 IMPACT ON PRICES 97
4.18 REGULATORY INCLINATION 97
4.18.1 GEOPOLITICAL SITUATION 97
4.18.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES 97
4.18.2.1 FREE TRADE AGREEMENTS: 97
4.18.2.2 ALLIANCES ESTABLISHMENTS: 97
4.18.3 STATUS ACCREDITATION (INCLUDING MFTN) 98
4.18.4 DOMESTIC COURSE OF CORRECTION 98
4.18.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS: 98
4.18.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS: 98
4.19 PRICE INDEX 98
5 REGULATORY FRAMEWORK 99
6 MARKET OVERVIEW 109
6.1 DRIVERS 111
6.1.1 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS GLOBALLY 111
6.1.2 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATION 111
6.1.3 INCREASING SPORTS INJURIES & ACCIDENTS 112
6.1.4 INCREASING AWARENESS OF THERAPY BENEFITS 113
6.2 RESTRAINTS 114
6.2.1 LIMITED REIMBURSEMENT AND INSURANCE COVERAGE 114
6.2.2 AVAILABILITY OF ALTERNATIVE TREATMENT 115
6.3 OPPORTUNITIES 116
6.3.1 GROWTH IN HOME BASED THERAPY 116
6.3.2 POST-SURGICAL CARE & REHABILITATION 116
6.3.3 RISING LIFESTYLE-RELATED DISEASES 117
6.4 CHALLENGES 118
6.4.1 LACK OF STANDARDIZED THERAPY PROTOCOLS 118
6.4.2 ENSURING ACCURATE PRODUCT FIT AND CORRECT APPLICATION 119
7 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE 120
7.1 OVERVIEW 121
7.2 STATIC COMPRESSION THERAPY 124
7.2.1 COMPRESSION STOCKINGS 125
7.2.2 COMPRESSION BANDAGES 125
7.2.3 COMPRESSION SLEEVES 125
7.2.4 COMPRESSION WRAPS 125
7.2.5 COMPRESSION GLOVES/GAUNTLETS 125
7.3 DYNAMIC COMPRESSION THERAPY 126
7.3.1 PNEUMATIC COMPRESSION DEVICES 126
7.3.2 ADAPTIVE COMPRESSION THERAPY DEVICES 126
8 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TYPE 127
8.1 OVERVIEW 128
8.2 COMPRESSION BANDAGES 132
8.2.1 SHORT STRETCH BANDAGES 133
8.2.2 LONG STRETCH BANDAGES 133
8.2.3 MULTILAYER COMPRESSION BANDAGES 133
8.3 COMPRESSION GARMENTS FOR LYMPHEDEMA 134
8.3.1 LEG GARMENTS 135
8.3.2 ARM SLEEVES 135
8.3.3 HAND GLOVES 135
8.3.4 TORSO/TRUNK GARMENTS 135
8.3.5 FACE/HEAD GARMENTS 135
8.4 COMPRESSION STOCKINGS FOR VENOUS DISEASES 136
8.4.1 BELOW KNEE STOCKINGS 137
8.4.2 THIGH HIGH STOCKINGS 137
8.4.3 PANTYHOSE/FULL LEG STOCKINGS 137
8.4.4 MATERNITY STOCKINGS 137
8.5 COMPRESSION WRAPS 137
8.6 PNEUMATIC COMPRESSION DEVICES 138
8.7 COMPRESSION HOSIERY & GAUNTLETS 138
9 NORTH AMERICA COMPRESSION THERAPY MARKET, BY APPLICATION 139
9.1 OVERVIEW 140
9.2 VARICOSE VEINS 144
9.3 LYMPHEDEMA 144
9.4 CHRONIC VENOUS INSUFFICIENCY (CVI) 145
9.5 DEEP VEIN THROMBOSIS (DVT) 145
9.6 VENOUS LEG ULCERS 146
9.7 WOUND CARE 146
9.8 SPORTS INJURY MANAGEMENT 147
10 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PATIENT GROUP 148
10.1 OVERVIEW 149
10.2 ADULT 152
10.3 GERIATRIC 153
10.4 PEDIATRIC 153
11 NORTH AMERICA COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL 154
11.1 OVERVIEW 155
11.2 MODERATE COMPRESSION 158
11.3 STRONG COMPRESSION 159
11.4 MILD COMPRESSION 160
11.5 VERY STRONG COMPRESSION 160
12 NORTH AMERICA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS 161
12.1 OVERVIEW 162
12.2 HOSPITALS 166
12.2.1 BANDAGES 167
12.2.2 POST-OPERATIVE COMPRESSION STOCKINGS 167
12.2.3 PNEUMATIC COMPRESSION DEVICES 167
12.3 RETAIL PHARMACIES 167
12.3.1 MILD TO MODERATE COMPRESSION STOCKINGS 168
12.3.2 COMPRESSION BANDAGES 168
12.3.3 SLEEVES AND GAUNTLETS 168
12.4 ECOMMERCE PLATFORMS 169
12.4.1 COMPRESSION STOCKINGS & GARMENTS 170
12.4.2 COMPRESSION WRAPS 170
12.4.3 SLEEVES, GLOVES, AND SOCKS 170
12.4.4 PORTABLE PNEUMATIC DEVICES 170
12.5 SPECIALTY CLINICS 170
12.5.1 HIGH-PRESSURE COMPRESSION GARMENTS 171
12.5.2 PNEUMATIC COMPRESSION PUMPS 171
12.5.3 CUSTOM WRAPS 171
12.6 MEDICAL DEVICE STORES 172
12.6.1 COMPRESSION STOCKINGS 173
12.6.2 COMPRESSION BANDAGES 173
12.6.3 COMPRESSION WRAPS 173
12.6.4 PNEUMATIC COMPRESSION DEVICES 173
12.6.5 ADAPTIVE COMPRESSION SYSTEMS 173
12.7 HOME HEALTHCARE PROVIDERS 174
12.7.1 COMPRESSION WRAPS 175
12.7.2 SLEEVES & GARMENTS 175
12.7.3 BANDAGES 175
12.7.4 PNEUMATIC PUMPS (PORTABLE) 175
12.8 NURSING HOMES/LONG-TERM CARE FACILITIES 175
12.8.1 COMPRESSION WRAPS 176
12.8.2 SLEEVES AND GAUNTLETS 176
12.8.3 ADAPTIVE GARMENTS 176
13 NORTH AMERICA COMPRESSION THERAPY MARKET, BY REGION 177
13.1 NORTH AMERICA 180
13.1.1 U.S. 189
13.1.2 CANADA 196
13.1.3 MEXICO 202
14 NORTH AMERICA COMPRESSION THERAPY MARKET: COMPANY LANDSCAPE 208
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 208
15 SWOT ANALYSIS 209
16 COMAPANY PROFILES 210
16.1 SOLVENTUM 210
16.1.1 COMPANY SNAPSHOT 210
16.1.2 REVENUE ANALYSIS 210
16.1.3 COMPANY SHARE ANALYSIS 211
16.1.4 PRODUCT PORTFOLIO 211
16.1.5 RECENT DEVELOPMENT 211
16.2 CARDINAL HEALTH 212
16.2.1 COMPANY SNAPSHOT 212
16.2.2 REVENUE ANALYSIS 212
16.2.3 COMPANY SHARE ANALYSIS 213
16.2.4 PRODUCT PORTFOLIO 213
16.2.5 RECENT DEVELOPMENT 214
16.3 SMITH+NEPHEW 215
16.3.1 COMPANY SNAPSHOT 215
16.3.2 REVENUE ANALYSIS 215
16.3.3 COMPANY SHARE ANALYSIS 216
16.3.4 PRODUCT PORTFOLIO 216
16.3.5 RECENT DEVELOPMENT 217
16.4 ESSITY AKTIEBOLAG (PUBL) 218
16.4.1 COMPANY SNAPSHOT 218
16.4.2 REVENUE ANALYSIS 218
16.4.3 COMPANY SHARE ANALYSIS 219
16.4.4 PRODUCT PORTFOLIO 219
16.4.5 RECENT DEVELOPMENT 221
16.5 PAUL HARTMANN AG 222
16.5.1 COMPANY SNAPSHOT 222
16.5.2 REVENUE ANALYSIS 222
16.5.3 COMPANY SHARE ANALYSIS 223
16.5.4 PRODUCT PORTFOLIO 223
16.5.5 RECENT DEVELOPMENT 223
16.6 ADIDAS AG 224
16.6.1 COMPANY SNAPSHOT 224
16.6.2 REVENUE ANALYSIS 224
16.6.3 PRODUCT PORTFOLIO 225
16.6.4 RECENT DEVELOPMENT 225
16.7 AIROS MEDICAL, INC. 226
16.7.1 COMPANY SNAPSHOT 226
16.7.2 PRODUCT PORTFOLIO 226
16.7.3 RECENT DEVELOPMENT 227
16.8 ARJO 228
16.8.1 COMPANY SNAPSHOT 228
16.8.2 REVENUE ANALYSIS 228
16.8.3 PRODUCT PORTFOLIO 229
16.8.4 RECENT DEVELOPMENTS 229
16.9 BAUERFEIND 230
16.9.1 COMPANY SNAPSHOT 230
16.9.2 PRODUCT PORTFOLIO 230
16.9.3 RECENT DEVELOPMENT 231
16.10 BIOCOMPRESSION SYSTEMS 232
16.10.1 COMPANY SNAPSHOT 232
16.10.2 PRODUCT PORTFOLIO 232
16.10.3 RECENT DEVELOPMENT 232
16.11 CALZE G.T.S.R.L 233
16.11.1 COMPANY SNAPSHOT 233
16.11.2 PRODUCT PORTFOLIO 233
16.11.3 RECENT DEVELOPMENT 234
16.12 CONVATEC GROUP PLC 235
16.12.1 COMPANY SNAPSHOT 235
16.12.2 PRODUCT PORTFOLIO 235
16.12.3 RECENT DEVELOPMENT 236
16.13 ENOVIS CORPORATION 237
16.13.1 COMPANY SNAPSHOT 237
16.13.2 REVENUE ANALYSIS 237
16.13.3 BRAND PORTFOLIO 238
16.13.4 RECENT DEVELOPMENTS 238
16.14 GETINGE 239
16.14.1 COMPANY SNAPSHOT 239
16.14.2 REVENUE ANALYSIS 239
16.14.3 PRODUCT PORTFOLIO 240
16.14.4 RECENT DEVELOPMENT 240
16.15 HUNTLEIGH HEALTHCARE LIMITED 241
16.15.1 COMPANY SNAPSHOT 241
16.15.2 PRODUCT PORTFOLIO 241
16.15.3 RECENT DEVELOPMENT 242
16.16 JUZO 243
16.16.1 COMPANY SNAPSHOT 243
16.16.2 PRODUCT PORTFOLIO 243
16.16.3 RECENT DEVELOPMENT 244
16.17 LOHMANN & RAUSCHER GMBH & CO. KG 245
16.17.1 COMPANY SNAPSHOT 245
16.17.2 PRODUCT PORTFOLIO 245
16.17.3 RECENT DEVELOPMENT 246
16.18 MCKESSON MEDICAL-SURGICAL INC. 247
16.18.1 COMPANY SNAPSHOT 247
16.18.2 REVENUE ANALYSIS 248
16.18.3 PRODUCT PORTFOLIO 248
16.18.4 RECENT DEVELOPMENT 249
16.19 MEDLINE INDUSTRIES, LP 250
16.19.1 COMPANY SNAPSHOT 250
16.19.2 PRODUCT PORTFOLIO 250
16.19.3 RECENT DEVELOPMENTS 251
16.20 MEDI GMBH & CO. KG 252
16.20.1 COMPANY SNAPSHOT 252
16.20.2 PRODUCT PORTFOLIO 252
16.20.3 RECENT DEVELOPMENT 253
16.21 MEGO AFEK LTD. 254
16.21.1 COMPANY SNAPSHOT 254
16.21.2 PRODUCT PORTFOLIO 254
16.21.3 RECENT DEVELOPMENT 256
16.22 MOLNLYCKE AB 257
16.22.1 COMPANY SNAPSHOT 257
16.22.2 PRODUCT PORTFOLIO 257
16.22.3 RECENT DEVELOPMENT 258
16.23 NIKE, INC. 259
16.23.1 COMPANY SNAPSHOT 259
16.23.2 REVENUE ANALYSIS 259
16.23.3 PRODUCT PORTFOLIO 260
16.23.4 RECENT DEVELOPMENT 260
16.24 OFA BAMBERG GMBH 261
16.24.1 COMPANY SNAPSHOT 261
16.24.2 PRODUCT PORTFOLIO 261
16.24.3 RECENT DEVELOPMENT 262
16.25 OSSUR 263
16.25.1 COMPANY SNAPSHOT 263
16.25.2 RECENT FINANCIALS 263
16.25.3 PRODUCT PORTFOLIO 264
16.25.4 RECENT DEVELOPMENT 265
16.26 SIGVARIS GROUP 266
16.26.1 COMPANY SNAPSHOT 266
16.26.2 PRODUCT PORTFOLIO 266
16.26.3 RECENT DEVELOPMENT 266
16.27 TACTILE MEDICAL 267
16.27.1 COMPANY SNAPSHOT 267
16.27.2 REVENUE ANALYSIS 267
16.27.3 PRODUCT PORTFOLIO 268
16.27.4 RECENT DEVELOPMENT 268
16.28 THERMOTEK 270
16.28.1 COMPANY SNAPSHOT 270
16.28.2 PRODUCT PORTFOLIO 270
16.28.3 RECENT DEVELOPMENT 270
16.29 THUASNE, SAS 271
16.29.1 COMPANY SNAPSHOT 271
16.29.2 PRODUCT PORTFOLIO 271
16.29.3 RECENT DEVELOPMENT 271
16.30 ZIMMER BIOMET 272
16.30.1 COMPANY SNAPSHOT 272
16.30.2 REVENUE ANALYSIS 273
16.30.3 PRODUCT PORTFOLIO 273
16.30.4 RECENT DEVELOPMENTS 274
17 QUESTIONNAIRE 275
18 RELATED REPORTS 279
?
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.